Pulmonology Articles

Pulmonology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Saketkoo LA et al. - MMF is safe, well tolerated, and allows reduction or discontinuation of prednisone without worsening of symptoms or objective progression of disease. MMF is less toxic and its targeted antifibrotic properties make it a potentially more effective agent than CYC that may supplant it as a first-line agent or provide sensible post-CYC maintenance or synergistic strategy in the treatment of CTD-ILD.

Related Articles

Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts
Arthritis & Rheumatism, 11/11/09    Relevance Score: 69%

Lung cancer: a biologically different disease in women?
Women's Health, 10/30/09    Relevance Score: 68%

Radiochemotherapy in small-cell lung cancer
Expert Review of Anticancer Therapy, 10/20/09    Relevance Score: 68%

Nocturnal hypoxia and sleep disturbances in cystic fibrosis
Pediatric Pulmonology, 10/14/09    Relevance Score: 68%

Risk of Acute Exacerbation After Video-assisted Thoracoscopic Lung Biopsy for Interstitial Lung Disease
Journal of Bronchology, 10/14/09    Relevance Score: 68%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address